Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Data processor with virtual machine management
Hydrating lounge chair
Micromechanical component, device for beam deflection of monochromatic light, and spectrometer
Pet burial pod
Phenethanolamine derivatives for treatment of respiratory diseases
High-speed comparator with asymmetric frequency response
High performance strained source-drain structure and method of fabricating the same
  Randomly Featured Patents
Injecting virtualization events in a layered virtualization architecture
Three-terminal spin-torque oscillator (STO)
Method and apparatus to provide guidance to support wireless connectivity
Methods and compositions for concentrating secreted recombinant protein
Bonding method
Adaptive array wireless communication apparatus, reception level display method, reception level adjusting method, reception level display program and reception level adjusting program
Waveguide-microstrip line converter
Simulated reflector lamp using par lamp components
Process for the production and purification of propylene glycol
Watch box